Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Journal of Neuro-Oncology
Erschienen in:

03.09.2021 | Laboratory Investigation

LINC00152 acts as a potential marker in gliomas and promotes tumor proliferation and invasion through the LINC00152/miR-107/RAB10 axis

verfasst von: Gang Peng, Jun Su, Songhua Xiao, Qing Liu

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Aberrant expression of long noncoding RNAs plays a pivotal role in tumorigenesis. Recently, several studies have showed that the LINC00152 gene is upregulated in a variety of tumors and plays an oncogene role; however, its underlying molecular mechanisms in glioblastoma remain unclear. In this study, we prepare to investigate the biological role and underlying molecular mechanisms of LINC00152 in glioblastoma cells.

Methods

Bioinformatics analysis to identify LINC00152 expression, Cell Counting kit-8 assay and Colony formation assay were used to evaluate proliferation, Flow cytometric analysis was used to evaluate apoptosis, Cell Matrigel invasion assay and Wound healing assay was used to evaluate invasion, Western blot analysis to check protein expression level, Mouse xenograft models was used to check cell proliferation in vivo.

Results

In this study, we found that LINC00152 was upregulated in gliomas and its expression was significantly associated with high tumor aggressiveness and poor outcomes for glioma patients. Functionally, the knockdown of LINC00152 not only inhibited malignant behaviors of glioma, such as proliferation and invasion of glioma cells and induced apoptosis in vitro but also suppressed tumorigenesis in vivo. Mechanistically, results of the bioinformatics analysis and experimental studies confirmed that LINC00152 and RAB10 as the targets of miR-107, and LINC00152 might act as a sponge for miR-107 to regulate the expression of RAB10 in glioblastoma. Additionally, silencing miR-107 reversed the effects induced by LINC00152 knockdown on glioblastoma cells both in vitro and in vivo.

Conclusion

Our data suggested that LINC00152 is a candidate prognostic marker of glioma, and that the LINC00152/MIR-107/RAB10 axis plays a pivotal role in regulation of the glioma malignancy, and therefore, targeting the axis might be an effective therapeutic strategy to treat glioma.

Graphic abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, Delattre JY (2012) Primary brain tumours in adults. Lancet 379:1984–1996PubMedCrossRef
3.
4.
Wang Z, Yang J, Xu G, Wang W, Liu C, Yang H, Yu Z, Lei Q, Xiao L, Xiong J, Zeng L, Xiang J, Ma J, Li G, Wu M (2015) Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. Oncotarget 6:3147–3164PubMedCrossRef
5.
Furnari FB, Cloughesy TF, Cavenee WK, Mischel PS (2015) Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma. Nat Rev Cancer 15:302–310PubMedPubMedCentralCrossRef
6.
Yuan J, Xiao G, Peng G, Liu D, Wang Z, Liao Y, Liu Q, Wu M, Yuan X (2015) MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ. Biochem Biophys Res Commun 457:171–176PubMedCrossRef
7.
Omuro A, Deangelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850PubMedCrossRef
8.
Beermann J, Piccoli MT, Viereck J, Thum T (2016) Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev 96:1297–1325PubMedCrossRef
9.
Deguchi S, Katsushima K, Hatanaka A, Shinjo K, Ohka F, Wakabayashi T, Zong H, Natsume A, Kondo Y (2017) Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis. Oncogene 36:4629–4640PubMedCrossRef
10.
Fan C, Tang Y, Wang J, Xiong F, Guo C, Wang Y, Zhang S, Gong Z, Wei F, Yang L, He Y, Zhou M, Li X, Li G, Xiong W, Zeng Z (2017) Role of long non-coding RNAs in glucose metabolism in cancer. Mol Cancer 16:130PubMedPubMedCentralCrossRef
11.
Gomes CC, De Sousa SF, Calin GA, Gomez RS (2017) The emerging role of long noncoding RNAs in oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 123:235–241PubMedCrossRef
12.
13.
14.
Floris G, Zhang L, Follesa P, Sun T (2017) Regulatory role of circular RNAs and neurological disorders. Mol Neurobiol 54:5156–5165PubMedCrossRef
15.
Fang XY, Pan HF, Leng RX, Ye DQ (2015) Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett 356:357–366PubMedCrossRef
16.
Wu X, Wang Y, Yu T, Nie E, Hu Q, Wu W, Zhi T, Jiang K, Wang X, Lu X, Li H, Liu N, Zhang J, You Y (2017) Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma. Neuro Oncol 19:1195–1205PubMedPubMedCentralCrossRef
17.
Pastori C, Kapranov P, Penas C, Peschansky V, Volmar CH, Sarkaria JN, Bregy A, Komotar R, St Laurent G, Ayad NG, Wahlestedt C (2015) The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation. Proc Natl Acad Sci USA 112:8326–8331PubMedPubMedCentralCrossRef
18.
Zhang JX, Han L, Bao ZS, Wang YY, Chen LY, Yan W, Yu SZ, Pu PY, Liu N, You YP, Jiang T, Kang CS, Chinese Glioma Cooperative G (2013) HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol 15:1595–1603PubMedPubMedCentralCrossRef
19.
Guo H, Hu G, Yang Q, Zhang P, Kuang W, Zhu X, Wu L (2016) Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells. Oncotarget 7:81806–81814PubMedPubMedCentralCrossRef
20.
Zhu Y, Zhang X, Qi L, Cai Y, Yang P, Xuan G, Jiang Y (2016) HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas. Oncotarget 7:14429–14440PubMedPubMedCentralCrossRef
21.
Jia P, Cai H, Liu X, Chen J, Ma J, Wang P, Liu Y, Zheng J, Xue Y (2016) Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells by inhibiting microRNA-29a. Cancer Lett 381:359–369PubMedCrossRef
22.
Katsushima K, Natsume A, Ohka F, Shinjo K, Hatanaka A, Ichimura N, Sato S, Takahashi S, Kimura H, Totoki Y, Shibata T, Naito M, Kim HJ, Miyata K, Kataoka K, Kondo Y (2016) Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun 7:13616PubMedPubMedCentralCrossRef
23.
Sa L, Li Y, Zhao L, Liu Y, Wang P, Liu L, Li Z, Ma J, Cai H, Xue Y (2017) The role of HOTAIR/miR-148b-3p/USF1 on regulating the permeability of BTB. Front Mol Neurosci 10:194PubMedPubMedCentralCrossRef
24.
Yu H, Xue Y, Wang P, Liu X, Ma J, Zheng J, Li Z, Li Z, Cai H, Liu Y (2017) Knockdown of long non-coding RNA XIST increases blood-tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137. Oncogenesis 6:e303PubMedPubMedCentralCrossRef
25.
Yu M, Xue Y, Zheng J, Liu X, Yu H, Liu L, Li Z, Liu Y (2017) Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway. Mol Cancer 16:110PubMedPubMedCentralCrossRef
26.
Yu Y, Yang J, Li Q, Xu B, Lian Y, Miao L (2017) LINC00152: A pivotal oncogenic long non-coding RNA in human cancers. Cell Prolif 50:e12349PubMedCentralCrossRef
27.
Teng W, Qiu C, He Z, Wang G, Xue Y, Hui X (2017) Linc00152 suppresses apoptosis and promotes migration by sponging miR-4767 in vascular endothelial cells. Oncotarget 8:85014–85023PubMedPubMedCentralCrossRef
28.
Chen QN, Chen X, Chen ZY, Nie FQ, Wei CC, Ma HW, Wan L, Yan S, Ren SN, Wang ZX (2017) Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression. Mol Cancer 16:17PubMedPubMedCentralCrossRef
29.
Feng S, Zhang J, Su W, Bai S, Xiao L, Chen X, Lin J, Reddy RM, Chang AC, Beer DG, Chen G (2017) Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer. Sci Rep 7:2982PubMedPubMedCentralCrossRef
30.
Ji J, Tang J, Deng L, Xie Y, Jiang R, Li G, Sun B (2015) LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway. Oncotarget 6:42813–42824PubMedPubMedCentralCrossRef
31.
Chen L, Li ZY, Xu SY, Zhang XJ, Zhang Y, Luo K, Li WP (2016) Upregulation of miR-107 inhibits glioma angiogenesis and VEGF expression. Cell Mol Neurobiol 36:113–120PubMedCrossRef
32.
Jiang W, Liu J, Xu T, Yu X (2016) MiR-329 suppresses osteosarcoma development by downregulating Rab10. FEBS Lett 590:2973–2981PubMedCrossRef
33.
Wang W, Jia WD, Hu B, Pan YY (2017) RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma. Oncotarget 8:26434–26447PubMedPubMedCentralCrossRef
34.
Stupp R, Hegi ME, Mason WP, Van Den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation For R, Treatment of Cancer Brain T, Radiation Oncology G, and National Cancer Institute of Canada Clinical Trials G (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466PubMedCrossRef
35.
36.
Wu Y, Tan C, Weng WW, Deng Y, Zhang QY, Yang XQ, Gan HL, Wang T, Zhang PP, Xu MD, Wang YQ, Wang CF (2016) Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma. Am J Cancer Res 6:285–299PubMedPubMedCentral
37.
Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1350–1354PubMedCrossRef
38.
Cai J, Zhang J, Wu P, Yang W, Ye Q, Chen Q, Jiang C (2018) Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-kappaB pathway. J Neurooncol 140:225PubMedCrossRef
39.
Liu X, Yidayitula Y, Zhao H, Luo Y, Ma X, Xu M (2018) LncRNA LINC00152 promoted glioblastoma progression through targeting the miR-107 expression. Environ Sci Pollut Res Int 25:17674–17681PubMedCrossRef
40.
41.
42.
Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H, Kong J, Ding K, Shen HM, Wu H, Xia D, Wu Y (2017) Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Mol Cancer 16:118PubMedPubMedCentralCrossRef
43.
Liu D, Li Y, Luo G, Xiao X, Tao D, Wu X, Wang M, Huang C, Wang L, Zeng F, Jiang G (2017) LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2. Cancer Lett 388:281–291PubMedCrossRef
44.
Cai Q, Wang Z, Wang S, Weng M, Zhou D, Li C, Wang J, Chen E, Quan Z (2017) Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1alpha via miR-138. Open Biol 7:160247PubMedPubMedCentralCrossRef
45.
Liu D, Gao M, Wu K, Zhu D, Yang Y, Zhao S (2019) LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153–3p/FYN axis. Biomed Pharmacother 112:108654PubMedCrossRef
46.
Ouyang T, Zhang Y, Tang S, Wang Y (2019) Long non-coding RNA LINC00052 regulates miR-608/EGFR axis to promote progression of head and neck squamous cell carcinoma. Exp Mol Pathol 111:104321PubMedCrossRef
47.
Sun Z, Guo X, Zang M, Wang P, Xue S, Chen G (2019) Long non-coding RNA LINC00152 promotes cell growth and invasion of papillary thyroid carcinoma by regulating the miR-497/BDNF axis. J Cell Physiol 234:1336–1345PubMedCrossRef
48.
Jaldin-Fincati JR, Pavarotti M, Frendo-Cumbo S, Bilan PJ, Klip A (2017) Update on GLUT4 vesicle traffic: a cornerstone of insulin action. Trends Endocrinol Metab 28:597–611PubMedCrossRef
49.
Just WW, Peranen J (2016) Small GTPases in peroxisome dynamics. Biochim Biophys Acta 1863:1006–1013PubMedCrossRef
50.
Sano H, Peck GR, Kettenbach AN, Gerber SA, Lienhard GE (2011) Insulin-stimulated GLUT4 protein translocation in adipocytes requires the Rab10 guanine nucleotide exchange factor Dennd4C. J Biol Chem 286:16541–16545PubMedPubMedCentralCrossRef
51.
Lerner DW, Mccoy D, Isabella AJ, Mahowald AP, Gerlach GF, Chaudhry TA, Horne-Badovinac S (2013) A Rab10-dependent mechanism for polarized basement membrane secretion during organ morphogenesis. Dev Cell 24:159–168PubMedPubMedCentralCrossRef
52.
English AR, Voeltz GK (2013) Rab10 GTPase regulates ER dynamics and morphology. Nat Cell Biol 15:169–178PubMedCrossRef
53.
Wang Z, Guo Q, Wang R, Xu G, Li P, Sun Y, She X, Liu Q, Chen Q, Yu Z, Liu C, Xiong J, Li G, Wu M (2016) The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells. J Hematol Oncol 9:130PubMedPubMedCentralCrossRef
54.
Peng G, Yuan X, Yuan J, Liu Q, Dai M, Shen C, Ma J, Liao Y, Jiang W (2015) miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL. Mol Cell Biochem 409:103–111PubMedCrossRef
55.
Su J, Long W, Ma Q, Xiao K, Li Y, Xiao Q, Peng G, Yuan J, Liu Q (2019) Identification of a tumor microenvironment-related eight-gene signature for predicting prognosis in lower-grade gliomas. Front Genet 10:1143PubMedPubMedCentralCrossRef
56.
Su J, Ma Q, Long W, Tang H, Wu C, Luo M, Wang X, Xiao K, Li Y, Xiao Q, Zhang C, Li H, Liu Q (2019) LCTL is a prognostic biomarker and correlates with stromal and immune infiltration in gliomas. Front Oncol 9:1083PubMedPubMedCentralCrossRef
Metadaten
Titel
LINC00152 acts as a potential marker in gliomas and promotes tumor proliferation and invasion through the LINC00152/miR-107/RAB10 axis
verfasst von
Gang Peng
Jun Su
Songhua Xiao
Qing Liu
Publikationsdatum
03.09.2021
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2021
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-021-03836-1

Weitere Artikel der Ausgabe 3/2021

Impact of the COVID-19 pandemic on neuro-oncology outcomes

  • Zur Zeit gratis
  • COVID-19
  • Clinical Study

Risks and neurological benefits of meningioma surgery in elderly patients compared to young patients

  • Open Access
  • Clinical Study

Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1

  • Topic Review

Cerebrospinal fluid diversion for leptomeningeal metastasis: palliative, procedural and oncologic outcomes

  • Clinical Study

Vision-related quality-of-life in pediatric primary brain tumor patients

  • Clinical Study

Intraoperative 3 T MRI is more correlative to residual disease extent than early postoperative MRI

  • Clinical Study

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Erneut Hinweise für Neuroprotektion durch Gürtelroseimpfung

Ergebnisse eines kürzlich publizierten „natürlichen Experiments“ in Wales legten nahe, dass eine Herpes-Zoster-Impfung das Demenzrisiko senkt. Jetzt hat das Studienteam ähnliche Daten aus Australien publiziert, die in die gleiche Richtung zeigen. Offene Fragen bleiben allerdings so oder so.

Podcast

Leben statt zu Überleben: Post-Intensive-Care-Syndrom

Immer mehr Menschen überleben kritische Erkrankungen. Aber Beatmung, Sedierung und die Eindrücke der Intensivstation hinterlassen Spuren. Das Post-Intensive-Care-Syndrom kann die Folge sein. Es ist nicht nur eine Herausforderung für Kliniken, sondern auch Hausarztpraxen. Mit Allgemeinmediziner Prof. Dr. med. Konrad Schmidt sprechen wir in dieser Folge darüber, wie die Überlebenden wieder ins Leben finden können.

Zeitschrift für Allgemeinmedizin, DEGAM

Ehe schützt nicht vor Demenz

  • 25.04.2025
  • Demenz
  • Nachrichten

Eigentlich leben Verheiratete länger und gesünder. Eine aktuelle Untersuchung kommt jedoch zu dem überraschenden Schluss, dass sie eher an Demenz erkranken als nie Verheiratete, Geschiedene oder Verwitwete.

Lohnt sich die Karotis-Revaskularisation?

Die medikamentöse Therapie für Menschen mit Karotisstenosen hat sich in den vergangenen Dekaden verbessert. Braucht es also noch einen invasiven Eingriff zur Revaskularisation der Halsschlagader bei geringem bis moderatem Risiko für einen ipsilateralen Schlaganfall?

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise